John LaRocca - 18 Mar 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC

Role
General Counsel
Signature
John LaRocca
Issuer symbol
N/A
Transactions as of
18 Mar 2022
Net transactions value
$0
Form type
4
Filing time
22 Mar 2022, 20:29:13 UTC
Previous filing
23 Feb 2022
Next filing
16 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Award $0 +19,015 +54% $0.000000 54,356 18 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AERI Stock Option (right to buy) Award $0 +65,941 $0.000000 65,941 18 Mar 2022 Common Stock 65,941 $8.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of March 18, 2022.
F2 This Option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of March 18, 2022.